Postsurgical osteomyelitis caused by Enterobacter sakazakii in a healthy young man

Journal of Chemotherapy

Volumn 19, Issue 1, 2007, Pages 94-96

  Corti, Giampaolo ^a   Panunzi, I ^a   Losco, M ^a   Buzzi, R ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antimicrobial resistance; Enterobacter sakazakii; Osteomyelitis; Surgical infection

Indexed keywords

GENTAMICIN; LEVOFLOXACIN; VANCOMYCIN;

ADULT; ANAMNESIS; ARTICLE; BACTERIUM CULTURE; BLOOD EXAMINATION; CASE REPORT; CLINICAL FEATURE; ENTEROBACTER SAKAZAKII; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MALE; OSTEOMYELITIS; PATHOGENESIS; PHYSICAL EXAMINATION; POSTOPERATIVE INFECTION; TREATMENT OUTCOME;

EID: 33846980769     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.1.94     Document Type: Article

References (16)

1. Farmer JJ III, Asbury MA, Hickman FW, Brenner DJ, and the Enterobacteriaceae study group. Enterobacter sakazakii: a new species of "Enterobacteriaceae" isolated from clinical materials. Int J Syst Bacteriol 1980; 3: 569-584.
2. Nazarowec-White M, Farber JM. Enterobacter sakazakii: a review. Int J Food Microbiol 1997; 34:103-113.
3. Bar-Oz B, Preminger A, Peleg O, Block C, Arad I. Enterobacter sakazakii infection in the newborn. Acta Paediatr 2001; 90: 356-358.
4. Van Acker J, De Smet F, Muyldermans G, Bougatef A, Naessens A, Lauwers S. Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol 2001; 39: 293-297.
5. Farber JM. Enterobacter sakazakii-new foods for thought? Lancet 2004; 363: 5-6.
6. Lai KK. Enterobacter sakazakii infection among neonates, infants, children, and adults: case reports and a review of the literature. Medicine 2001; 80: 113-122.
7. Gurtler JB, Kornacki JL, Beuchat LR. Enterobacter sakazakii: a coliform of increased concern to infant health. Int J Food Microbiol 2005; 104: 1-34.
8. Pribyl C, Salzer R, Beskin J et al. Aztreonam in the treatment of serious orthopedic infections. Am J Med 1985; 78 (Suppl 2A): 51-56.
9. Lehner A, Stephan R. Microbiological, epidemiological, and food safety aspects of Enterobacter sakazakii. J Food Prot 2004; 67: 2850-2857.
10. Ongrádi J. Vaginal infection by Enterobacter sakazakii. Sex Transm Infect 2002; 78: 467.
11. Muytjens HL, van der Rose-van de Repe J. Comparative in-vitro susceptibilities of eight Enterobacter species, with special reference to Enterobacter sakazakii. Antimicrob Agents Chemother 1986; 29: 367-370.
12. Burwen DR, Banerjee SN, Gaynes RP. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis 1994; 170 : 1622-1625.
13. Pitout JD, Moland ES, Sanders CC, Thomson KS, Fitzsimmons SR. Beta-lactamases and detection of beta-lactam resistance in Enterobacter spp. Antimicrob Agents Chemother 1997; 41: 35-39.
14. Ho PL, Shek RHL, Chow KH et al. Detection and characterization of extended-spectrum β-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. J Antimicrob Chemother 2005; 55: 326-332.
15. Pfaller MA, Jones TN, MYSTIC Study Group (Europe). Antimicrobial susceptibility of inducible AmpC β-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents 2002; 19: 383-388.
16. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 2004; 50: 59-69.